◆英語タイトル:CooperVision Inc - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010118
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presbyopia; and offers a comprehensive collection of spherical, toric and multifocal products. The company offers its products under various categories such as MyDay, clariti 1 day family and Biofinity family to meet the requirements of people with different types of vision problems. The company provides information regarding eye problems, eye health and supplements. It also provides instructions and information related to wearing contact lenses and their care. CooperVision is headquartered in Victor, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CooperVision Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
CooperVision Inc Company Overview 4
CooperVision Inc Company Snapshot 4
CooperVision Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CooperVision Inc – Pipeline Analysis Overview 7
CooperVision Inc – Key Facts 7
CooperVision Inc – Major Products and Services 8
CooperVision Inc Pipeline Products by Development Stage 9
CooperVision Inc Ongoing Clinical Trials by Trial Status 11
CooperVision Inc Pipeline Products Overview 13
Biofinity Energys 13
Biofinity Energys Product Overview 13
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens 14
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens Product Overview 14
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens Clinical Trial 15
MyDay Toric 16
MyDay Toric Product Overview 16
SiH Multifocal 17
SiH Multifocal Product Overview 17
CooperVision Inc – Key Competitors 18
CooperVision Inc – Key Employees 19
CooperVision Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
CooperVision Inc, Recent Developments 21
Dec 13, 2017: CooperVision Announces Nationwide Availability of Expanded Parameters for Avaira Vitality toric 21
Sep 13, 2017: LensFerry Now Offers EHR Integration; Automation Drives Practice Revenue 21
Sep 07, 2017: Together We’ve Made Biofinity Energys a Breakthrough Success 22
Jun 10, 2017: Three-year study says new contact lens therapy slows myopia progression in children by 59 percent 22
Jun 10, 2017: Three-Year Study Indicates Pioneering Contact Lens Therapy Effective in Slowing Myopia Progression in Children by 59% 23
Jun 05, 2017: CooperVision Receives Environmental Innovative Project of the Year, 12 Additional Environmental Sustainability and Occupational Health & Safety Honors 23
Apr 27, 2017: CooperVision Issues Call for Proposals for 5th Annual Science and Technology Awards Program 24
Mar 31, 2017: LensFerry S Adds Online Enrollment for Patient Ease-of-Purchase 25
Mar 30, 2017: CooperVision Becomes First Major Contact Lens Manufacturer to Join The Vision Council 25
Mar 27, 2017: CooperVision Affirms UPP on Biofinity Energys 26
Appendix 27
Methodology 27
About GlobalData 29
Contact Us 29
Disclaimer 30
List of Tables
CooperVision Inc Pipeline Products and Ongoing Clinical Trials Overview 4
CooperVision Inc Pipeline Products by Equipment Type 5
CooperVision Inc Pipeline Products by Indication 6
CooperVision Inc Ongoing Clinical Trials by Trial Status 6
CooperVision Inc, Key Facts 7
CooperVision Inc, Major Products and Services 8
CooperVision Inc Number of Pipeline Products by Development Stage 9
CooperVision Inc Pipeline Products Summary by Development Stage 10
CooperVision Inc Ongoing Clinical Trials by Trial Status 11
CooperVision Inc Ongoing Clinical Trials Summary 12
Biofinity Energys - Product Status 13
Biofinity Energys - Product Description 13
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Status 14
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Product Description 14
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - A Multi-center Dispensing Clinical Evaluation of MiSight Lenses 15
MiSight Dual-Focus Myopia Control 1-Day Soft Contact Lens - Efficacy and Safety of MiSight Contact Lenses in Reducing the Progression of Childhood Myopia, Not Pathological, Aged 8-12 Years Randomized Clinical Trial 15
MyDay Toric - Product Status 16
MyDay Toric - Product Description 16
SiH Multifocal - Product Status 17
SiH Multifocal - Product Description 17
CooperVision Inc, Key Employees 19
Glossary 28